Russo, PCosta, MSilva, Mde Sousa, ACarvalho, DSaiote, JMendes, M2017-11-102017-11-102017-05GE Port J Gastroenterol. 2017 May;24(3):147-150http://hdl.handle.net/10400.17/2784The continuous delivery of a levodopa/carbidopa gel suspension (Duodopa®) into the small bowel through a jejunal tube inserted via percutaneous endoscopic gastrostomy represents a new treatment method in advanced Parkinson disease. Some severe device-related complications have been described in the last few years. Some of them are associated with phytobezoar formation at the pigtail of the catheter. We present the case of a Parkinson disease patient treated with the Duodopa infusion system complicated by jejunal tube fistulization into the colon. We suggest a possible treatment strategy for this complication, which has not been described in the literature to date.engHSAC GASHSAC NEUCHLC CHBPTAntiparkinson AgentsParkinson DiseaseGastrointestinal EndoscopyGastrostomy/adverse effectsjournal article10.1159/000452694